RT Journal Article
SR Electronic
T1 Caution on Kidney Dysfunctions of 2019-nCoV Patients
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.02.08.20021212
DO 10.1101/2020.02.08.20021212
A1 Anti-2019-nCoV Volunteers
A1 Zhen Li
A1 Ming Wu
A1 Jie Guo
A1 Jiwei Yao
A1 Xiang Liao
A1 Siji Song
A1 Min Han
A1 Jiali Li
A1 Guangjie Duan
A1 Yuanxiu Zhou
A1 Xiaojun Wu
A1 Zhansong Zhou
A1 Taojiao Wang
A1 Ming Hu
A1 Xianxiang Chen
A1 Yu Fu
A1 Chong Lei
A1 Hailong Dong
A1 Yi Zhou
A1 Hongbo Jia
A1 Xiaowei Chen
A1 Junan Yan
YR 2020
UL http://medrxiv.org/content/early/2020/02/12/2020.02.08.20021212.abstract
AB Until 24:00 of February 7th 2020, 31774 laboratory-confirmed cases of novel coronavirus (2019-nCoV) infection have been reported, including 6101 severe cases in critical conditions and 722 deaths. The critical and urgent need at this moment is to find an effective treatment strategy with available means to prevent these thousands of severe inpatients from worsening and dying. It has been recently known that 2019-nCoV shares a common cellular mechanism with the severe acute respiratory syndrome-associated coronavirus (SARS-CoV). Thus, we surveyed a previous retrospective case study on SARS which showed that acute renal impairment was uncommon in SARS but carried a formidably high mortality (91.7%, 33 of 36 cases). Here we report an ongoing case study on kidney functions in 59 patients infected by 2019-nCoV (including 28 diagnosed as severe cases and 3 deaths). 63% (32/51) of the patients exhibited proteinuria, indicative of renal impairment. 19% (11/59) and 27% (16/59) of the patients had an elevated level of plasma creatinine and urea nitrogen respectively. The computerized tomography (CT) scan showed radiographic abnormalities of the kidneys in 100% (27/27) of the patients. Together, these multiple lines of evidence point to the idea that renal impairment is common in 2019-nCov patients, which may be one of the major causes of the illness by the virus infection and also may contribute to multi-organ failure and death eventually. Therefore, we strongly suggest exercising a high degree of caution in monitoring the kidney functions of 2019-nCoV patients and, very importantly, that applying potential interventions including continuous renal replacement therapies (CRRT) for protecting kidney functions as early as possible, particular for those with plasma creatinine rising, is key to preventing fatality.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was supported by grants from the “1000-Talents Program for Young Scholars” of China (X. Chen) and the “100-Talents Program for Elite Engineers” of the CAS (H. Jia).Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesPlease find all data at the following link (code: 7hjn ): https://pan.baidu.com/s/1yDg_jwSv1RckHuVa6_dhYA